These findings highlight a need for more stringent and standardized reporting guidelines relative to incidental findings, authors of the new study suggested.

The ACR Committee on Drugs and Contrast Media stated that exposure to the gadolinium-based contrast agent represents a “sufficiently low or possibly nonexistent” risk to patients.

These findings warrant serious consideration by physicians caring for pregnant women in the future, as the link between poor mental health and placental development remains “underappreciated.”

PET/CT saw the biggest gains, up almost 21% year-over-year compared to Q1 of 2022, with the group collecting $390M in revenue (up 14%). 

The draft update marks a shift from the task force's previous guidelines, which had endorsed screening beginning at age 50.

Researchers suggested these findings could be used as a noninvasive tool in creating more personalized treatment options for patients facing a cancer diagnosis that is invasive in nature. 

The policy changes forbid insurers from saddling patients with out-of-pocket costs for services associated with lung and breast cancer.

New findings indicate that monitoring times following renal mass biopsy could be revisited in many cases without posing risks to patients.